Pfizer
Market Cap: 12,189 Cr.
Current Price: 2,664
52 weeks High / Low 3840.00 / 2050.60
Book Value: 604.61
Stock P/E: 32.13
Dividend Yield: 0.75 %
ROCE: 21.48 %
ROE: 14.11 %
Sales Growth (3Yrs): 2.04 %
Listed on BSE and NSE
Company Website
Face Value: 10.00
Industry PBV:
EPS: 82.92
Graham: 1,062
Debt to equity: 0.00
Book value: 604.61
Price to Earning: 32.13
PEG Ratio: 2.71
Earning Power: 15.30 %
Return on equity: 14.11 %
Pledged percentage: 0.00 %
Intrinsic Value: 3,597
Industry PE:
Piotroski score: 6.00
Volume: 9,777
Market cap to quarterly profit: 127.24
Market Capitalization: 12,189 Cr.
Price to book value: 4.41
Return on assets: 13.87 %
Debt: 2.50 Cr.
Interest Coverage Ratio: 1,226
Promoter holding: 63.92 %
Unpledged promoter holding: 63.92 %
Sales last year: 1,969 Cr.
Pfizer came to India in 1950 through a company named Dumex. Its first production unit was set up at Darukhanna in Mumbai. It manufactured products like Protinex, Isonex, Becosules and Corex.In the year 1960, the company set up one more plant at Thane, near Mumbai for manufacturing and conducting product research. In 1965 Pfizer entered into a licence agreement with Pfizer Corporation for the use of Pfizer’s processes, technical know-how, etc to manufacture its existing products. Later in the year 1992, Dumex was amalgamated with Pfizer.
In India, Pfizer instituted the first ever Disease Management Programme -- Healthy Heart in Cardio Vascular Disease (Hypertension, Chronic Stable Angina and Dyslipidemia), in partnership with Apollo Hospital, Hyderabad and Apollo Hospital, Chennai
Six Pfizer brands feature among the Top 100 pharmaceutical brands in India, while two of Pfizer India's brands -- Corex (Cough Formulation) and Becosules (Multivitamin) -- continue to rank among the Top 15 pharmaceutical drug brands
The company’s manufacturing plant was ISO 14001 certified for its Environment Management System awarded by DNV Certification B.V, Netherlands .
In 2013 Pfizer Ltd and Wyeth Ltd decided to merge, creating a single Pfizer Brand.
Products
Prescription Drugs- Pfizer manufactures prescription drugs such as Viagra, Lyrica, Viagra, Dolonex Gel, Ponstan, Citralka Liquid, and many more.
Consumer Health- It produces over the counter formulations and drugs such as Benadryl cough, Coolmint Listerine Mouthwash, Rashfree, Caladryl, Sloans Balm, etc.
Animal Health- It manufactures products for animal care namely Amoxisol, Vanguard 5/L, Stafac, Furea, Qualidrops, Catosal, Bayrocin, Nutrimilk, etc.
Awards
In March 2011 Pfizer ranked first in the medicine and health care industry in an annual ranking conducted by Antal International, a global executive search firm.
In 2010 December Pfizer France Wins Oncology Medical Affairs Best Practice Award.
In a survey conducted by Ernst & Young on customer satisfaction, Pfizer was ranked HIGH in terms of Overall Satisfaction with the Services and Interactions.
The company was acknowledged for its product Exubera with 'Innovative Products of the Year' at Pharma Excellence Awards 2006
It received the Silver Award for its printing advertising on Gelusil brand at the ABBY-All India Awards for Creative Excellence.
Market Cap: 12,189 Cr.
Current Price: 2,664
52 weeks High / Low 3840.00 / 2050.60
Book Value: 604.61
Stock P/E: 32.13
Dividend Yield: 0.75 %
ROCE: 21.48 %
ROE: 14.11 %
Sales Growth (3Yrs): 2.04 %
Listed on BSE and NSE
Company Website
Face Value: 10.00
Industry PBV:
EPS: 82.92
Graham: 1,062
Debt to equity: 0.00
Book value: 604.61
Price to Earning: 32.13
PEG Ratio: 2.71
Earning Power: 15.30 %
Return on equity: 14.11 %
Pledged percentage: 0.00 %
Intrinsic Value: 3,597
Industry PE:
Piotroski score: 6.00
Volume: 9,777
Market cap to quarterly profit: 127.24
Market Capitalization: 12,189 Cr.
Price to book value: 4.41
Return on assets: 13.87 %
Debt: 2.50 Cr.
Interest Coverage Ratio: 1,226
Promoter holding: 63.92 %
Unpledged promoter holding: 63.92 %
Sales last year: 1,969 Cr.
No comments:
Post a Comment